Illumina, Inc. (ILMN)

NMS – Real vaqt narxi. Valyuta: USD

145.70

+3.19 (2.24%)

Yopilishda: May 12, 2026, 4:00 PM EDT

147.50

+1.80 (1.23%)

Bozordan keyin: May 12, 2026, 7:59 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Illumina, Inc. (ILMN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Illumina, Inc. (ILMN)

Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term

Here's Why Illumina (ILMN) is a Strong Growth Stock

ILMN Stock Up on Q1 Earnings & Revenue Beat, Margins Expand, '26 View Up

Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Videolar

Press-relizlar

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Illumina Announces Changes to Board of Directors

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

Search stocks

Illumina, Inc. (ILMN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Illumina, Inc. (ILMN)

Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term

Here's Why Illumina (ILMN) is a Strong Growth Stock

ILMN Stock Up on Q1 Earnings & Revenue Beat, Margins Expand, '26 View Up

Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics

AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Videolar

Press-relizlar

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

Illumina Announces Changes to Board of Directors

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing